Primary healthcare policy and vision for community pharmacy and pharmacists in Germany



Pharmacies, Primary Health Care, Delivery of Health Care, Integrated, Ambulatory Care, Community Health Services, Pharmacists, Community Pharmacy Services, Professional Practice, Germany


Germany is the highest populated country in Europe with a population of 82.3 million in 2019. As in many other developed countries, it has an aging population. Approximately 10% of the gross domestic product is spent on healthcare. The healthcare system is characterized by its accessibility. Patients are generally free to choose their primary care physicians, both family doctors and specialists, pharmacy, dentist, or emergency service. Up to a certain income, health insurance is mandatory with the statutory health insurance (SHI) system, covering 88% of the population. Major challenges are the lack of cooperation and integration between the different sectors and healthcare providers. This is expected to change with the introduction of a telematic infrastructure that is currently being implemented. It will not only connect all providers in primary and secondary care in a secure network but will also enable access to patients’ electronic record/medical data and at the same time switch from paper to electronic prescriptions. Approximately 52,000 of the 67,000 pharmacists are working in approximately 19,000 community pharmacies. These pharmacies are owner-operated by a pharmacist. Pharmacists may own up to three subsidiaries nearby to their main pharmacy. Community pharmacy practice mainly consists of dispensing drugs, counselling patients on drug therapy and safety, and giving advice on lifestyle and healthy living. Many cognitive pharmaceutical services have been developed and evaluated in the past 20 years. Discussions within the profession and with stakeholders on the national level on the roles and responsibilities of pharmacists have resulted in nationally agreed guidelines, curricula, and services. However, cognitive services remunerated by the SHI funds on the national level remain to be negotiated and sustainably implemented. A law passed in November 2020 by parliament will regulate the remuneration of pharmaceutical services by the SHI funds with an annual budget of EUR 150 million. The type of services and their remuneration remain to be negotiated in 2021. The profession has to continue on all levels to advocate for a change in pharmacy practice by introducing pharmacy services into routine care.


Download data is not yet available.


Federal Statistical Office.;jsessionid=E8C2F6CF5A2476C04A452E1CD0D1BFC1.internet8731 (accessed Oct 30, 2020).

Statista. Germany: population by age. Available from: (accessed Oct 30, 2020).

Busse R, Ognyanova D, Blümel M. [The German health care system: Stakeholders, data, analyses]. Stuttgart: Medizinisch Wissenschaftliche Verlagsgesellschaft; 2013.

Busse R. Disease management programs in Germany's statutory health insurance system. Health Aff (Millwood). 2004;23(3):56-67.

Schwabe U, Ludwig, WD. [Drug Report 2020]. Berlin: Springer; 2020.

Kringos DS, Boerma WGW, Hutchinson A, Saltman RB, eds. Building primary care in a changing Europe: Case studies. Copenhagen: European Observatory on Health Systems and Policies; 2015.

Schlette S, Lisac M, Blum K. Integrated primary care in Germany: the road ahead. Int J Integr Care. 2009;9:e14.

Knieps F, Amelung V, Wolf S. [Healthcare in regions difficult to cover: Basic principles, definitions, problem analyses]. GuS. 2012;66(6):8-19.

Schulte H, Schulz C. [Medical care centers: improving ambulatory care versus selection and exclusion of patient groups]. Baden-Baden: Nomos; 2007.

Eickhoff C, Schulz M. Pharmaceutical care in community pharmacies: practice and research in Germany. Ann Pharmacother. 2006;40(4):729-735.

Schmiedel K, Schlager H, Dörje F. Preventive counselling for public health in pharmacies in South Germany. Int J Clin Pharm. 2013;35(1):138-144.

ABDA. [German Pharmacies: Figures Data Facts 2020]. (accessed Oct 30, 2020).

Federal Ministry of Health. The German healthcare system - Strong. Reliable. Proven. (accessed Oct 30, 2020).

Amelung V, Hildebrandt H, Wolf S. Integrated care in Germany-a stony but necessary road!. Int J Integr Care. 2012;12:e16.

Sommer H, Dwenger A. [Action plan of the Federal Ministry of Health for improvement of medication safety in Germany : An inventory]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61(9):1062-1065.

Milstein R, Blankart CR. The Health Care Strengthening Act: The next level of integrated care in Germany. Health Policy. 2016;120(5):445-451.

gematik. [Legal foundations: Company for telematic applications of the electronic health card]. (accessed Oct 30, 2020).

Klein M. Minister-Premiere bei der conhIT: [Jens Spahn established a department for digitalization at the German Federal Ministry of Health]. (accessed Oct 30, 2020).

[Law for secure digital communication and applications in the health care system. E-Health act].*[@attr_id=%27bgbl115s2408.pdf%27]#__bgbl__%2F%2F*%5B%40attr_id%3D%27bgbl115s2408.pdf%27%5D__1601463267910 (accessed Oct 30, 2020).

[Law for better care through digitalization and innovation. Digital care act].*%5B%40attr_id%3D%27bgbl119s2562.pdf%27%5D__1602761776063 (accessed Oct 30, 2020).

ABDA. [Pharmacy 2030 - Perspectives on provision of pharmacy services in Germany]. (accessed Oct 30, 2020).

Rose O, Schaffert C, Czarnecki K, et al. Effect evaluation of an interprofessional medication therapy management approach for multimorbid patients in primary care: a cluster-randomized controlled trial in community care (WestGem study protocol). BMC Fam Pract. 2015;16:84.

Bundesapothekerkammer. [LeiKa: Catalogue of counselling and other services in phrmacies]. Available from: (accessed Oct 30, 2020).

Weissenborn M, Haefeli WE, Peters-Klimm F, Seidling HM. Interprofessional communication between community pharmacists and general practitioners: a qualitative study. Int J Clin Pharm. 2017;39(3):495-506.

[Committee pharmacists in diabetology. Cooperation - diabetes]. (accessed Oct 30, 2020).

Schulz M, Griese-Mammen N, Schumacher PM, et al. Development and implementation of blood pressure screening and referral guidelines for German community pharmacists. J Clin Hypertens (Greenwich). 2020;22(10):1807-1816.

Schmiedel K, Mayr A, Fießler C, Schlager H, Friedland K. Effects of the lifestyle intervention program GLICEMIA in people at risk for type 2 diabetes: a cluster-randomized controlled trial. Diabetes Care. 2015;38(5):937-939.

Schulz M, Verheyen F, Mühlig S, et al. Pharmaceutical care services for asthma patients: a controlled intervention study. J Clin Pharmacol. 2001;41(6):668-676.

Hämmerlein A, Müller U, Schulz M. Pharmacist-led intervention study to improve inhalation technique in asthma and COPD patients. J Eval Clin Pract. 2011;17(1):61-70.

Müller U, Hämmerlein A, Casper A, Schulz M. Community pharmacy-based intervention to improve self-monitoring of blood glucose in type 2 diabetic patients. Pharm Pract (Granada). 2006;4(4):195-203.

Seidling HM, Send AFJ, Bittmann J, et al. Medication review in German community pharmacies - Post-hoc analysis of documented drug-related problems and subsequent interventions in the ATHINA-project. Res Social Adm Pharm. 2017;13(6):1127-1134.

Schulz M, Griese-Mammen N, Anker SD, et al. Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial. Eur J Heart Fail. 2019;21(8):1012-1021.

[National disease management guidelines]. (accessed Oct 30, 2020).

Schulz M, Dalhoff K, Alsdorf E, et al. [National Asthma Care Guideline]. Berlin: AWMF; 2020.

Mangiapane S, Schulz M, Mühlig S, Ihle P, Schubert I, Waldmann HC. Community pharmacy-based pharmaceutical care for asthma patients. Ann Pharmacother. 2005;39(11):1817-1822.

[National disease management guideline for the treatment of type 2 diabetes]. 2013. Available from: (accessed Oct 30, 2020).

Bundesärztekammer. [National Diabetes Care Guideline: Structured training programs]. (accessed Oct 30, 2020).

Kommission Apotheker in der Diabetologie. [Consensus paper of the German Diabetes Society and the Federal Chamber of Pharmacists. Pharmaceutical care for people with diabetes and health counselling of people with a risk for diabetes: options and limitations]. (accessed Oct 30, 2020).

Bundesapothekerkammer. [Inquiry at the Regional Chambers of Pharmacists on the number of certified advances trainings conducted]; 2017.

[National disease management guideline chronic heart failure]. 3rd ed. Berlin. (accessed Oct 30, 2020).

Schwarz PE, Müller U, Schulz M, Hauner H, Landgraf R. [Prevention of type 2 diabetes in Germany--a challenge for health professionals]. Med Monatsschr Pharm. 2007;30(8):289-296.

Schwarz PE, Li J, Lindstrom J, Tuomilehto J. Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res. 2009;41(2):86-97.

[Coordination group on implementing and updating the action plan for improvement of medication safety (Version 2.0, updated version)]. (accessed Oct 30, 2020).

Wenger NS, Young RT. Quality indicators for continuity and coordination of care in vulnerable elders. J Am Geriatr Soc. 2007;55 Suppl 2:S285-S292.

Kuske S, Lessing C, Lux R, Schmitz A, Schrappe M. [Patient safety indicators for medication safety (AMTS-PSI): international status, transferability and validation]. Gesundheitswesen. 2012;74(2):79-86.

Committee on Identifying and Preventing Medication Errors. What can you do to avoid medication errors: fact sheet; Washington, DC: IOM; 2006.

Schulz M, Botermann L. [Basic preconditions for the electronic configuration of medication data with regard to the medication plan: Action plan of the Federal Ministry of Health to improve medication safety in Germany]. Available from: (accessed Oct 30, 2020).

Müller U, Schulz M, Mätzler M. [Electronically supported co-operation of physicians and pharmacists to improve medication safety in the ambulatory setting : The "Arzneimittelinitiative Sachsen-Thüringen" (ARMIN)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61(9):1119-1128.

Dormann H, Maas R, Eickhoff C, et al. [Standardized national medication plan : The pilot projects MetropolMediplan 2016, model region Erfurt, and PRIMA]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61(9):1093-1102.

[General practitioners disapprove of pharmacists administering influenza vaccinations]. (accessed Oct 30, 2020).

[Social Code Book V - Statutory Health Insurance. § 132j Regional model projects on influenza vaccinations in community pharmacies]. (accessed Oct 30, 2020).

Bundesapothekerkammer. [Guidelines and working materials: Influenza vaccination (model projects)]. (accessed Oct 30, 2020).

KBV - ABDA. [Future concept for drug provision: the ABDA-KBV-concept]. (accessed Oct 30, 2020).

Waltering I, Schwalbe O, Hempel G. [Information content of medication schedules prior to the implementation of the federal standard medication plan]. Z Evid Fortbild Qual Gesundhwes. 2016;115-116:24-32.

[ARMIN Medicines Initiative Saxony-Thuringia]. (accessed Oct 30, 2020).

Griese-Mammen N, Hersberger KE, Messerli M, et al. PCNE definition of medication review: reaching agreement. Int J Clin Pharm. 2018;40(5):1199-1208.

Bundesapothekerkammer. [Medication review: Guideline of the Federal Chamber of Pharmacists]. (accessed Oct 30, 2020).

Bergert FW, Braun M, Ehrenthal K, et al. [General practitioners guideline: Recommendations on the use of polymedication for adults and geriatric patients]. (accessed Oct 30, 2020).




How to Cite

Eickhoff C, Griese-Mammen N, Mueller U, Said A, Schulz M. Primary healthcare policy and vision for community pharmacy and pharmacists in Germany. Pharm Pract (Granada) [Internet]. 2021 Jan. 20 [cited 2021 Oct. 20];19(1):2248. Available from: